Thursday, November 12, 2026

EUR/CHF Is 1% Down In The Last 10 Sessions

ViaNews Editorial Team

February 17, 2023

EUR/CHF Is 1% Down In The Last 10 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.01% for the last 10 sessions. At 11:07 EST on Friday, 17 February, EUR/CHF (EURCHF) is $0.99.

EUR/CHF's yearly highs and lows, it's 4.932% up from its 52-week low and 5.897% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.29%, a negative 0.09%, and a positive 0.30%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.44% (last week), 0.38% (last month), and 0.30% (last quarter), respectively.

News about

  • Usd/jpy snaps two-day uptrend despite upbeat yields, hawkish fed talks. According to FXStreet on Wednesday, 15 February, "Moving on, a lack of major data/events from Japan puts the USD/JPY pair at the mercy of the US catalysts for clear directions. ", "That said, S&P 500 Futures trace Wall Street's downbeat closing to highlight the mildly offbeat mood and weigh on the USD/JPY prices, mainly due to the Japanese Yen's (JPY) traditional risk-safety allure."
  • Usd/jpy price analysis: bulls flirt with 133.00 inside monthly rising wedge. According to FXStreet on Wednesday, 15 February, "That said, the USD/JPY remains inside a one-month-old rising wedge bearish chart formation.", "Even if the quote rises past 133.60, a two-month-old horizontal resistance region near 134.50-70, will precede the 200-DMA level surrounding 136.90 to challenge the USD/JPY bulls."
  • Usd/jpy price analysis: back above 134.00, as bulls moved in and crushed the 200-dma. According to FXStreet on Wednesday, 15 February, "Even though the RSI shifted overbought, as long as it stays below 80, it portrays the USD/JPY in a strong uptrend. ", "Hence, the USD/JPY shifted bullish during the session, though a daily close above the 200-day EMA would keep bulls hopeful for further upside. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com